Q2 2024 |
307 |
$7.52B |
+$645M |
-$520M |
+$125M |
AVGO, MSFT, META, TFII, AAPL
|
13F-HR |
8/13/2024, 10:08 AM |
Q1 2024 |
316 |
$7.41B |
+$1.02B |
-$634M |
+$381M |
MSFT, AVGO, TFII, META, BGNE
|
13F-HR |
5/14/2024, 04:20 PM |
Q4 2023 |
320 |
$6.41B |
+$907M |
-$322M |
+$585M |
MSFT, AVGO, TFII, BGNE, META
|
13F-HR |
2/13/2024, 02:40 PM |
Q3 2023 |
330 |
$5.21B |
+$304M |
-$417M |
-$112M |
MSFT, AVGO, BGNE, TFII, META
|
13F-HR |
11/13/2023, 01:37 PM |
Q2 2023 |
345 |
$5.49B |
+$758M |
-$449M |
+$309M |
MSFT, AVGO, BGNE, TFII, ASML
|
13F-HR |
8/11/2023, 12:20 PM |
Q1 2023 |
297 |
$4.98B |
+$423M |
-$470M |
-$47.2M |
BGNE, MSFT, TFII, ASML, VALE
|
13F-HR |
5/15/2023, 11:41 AM |
Q4 2022 |
294 |
$4.63B |
+$266M |
-$545M |
-$279M |
BGNE, TFII, MSFT, VALE, ASML
|
13F-HR |
2/14/2023, 01:53 PM |
Q3 2022 |
281 |
$4.48B |
+$308M |
-$2.41B |
-$2.1B |
BGNE, MSFT, TFII, VALE, TSLA
|
13F-HR |
11/14/2022, 11:51 AM |
Q2 2022 |
285 |
$7.21B |
+$492M |
-$465M |
+$26.5M |
MSFT, BGNE, ASML, GOOG, VALE
|
13F-HR |
8/15/2022, 12:00 PM |
Q1 2022 |
293 |
$8.92B |
+$697M |
-$1.57B |
-$877M |
MSFT, VALE, ASML, TSLA, BGNE
|
Restatement |
5/19/2022, 02:28 PM |
Q4 2021 |
302 |
$10.8B |
+$927M |
-$854M |
+$73.1M |
MSFT, TSLA, META, ASML, BGNE
|
13F-HR |
2/14/2022, 02:36 PM |
Q3 2021 |
297 |
$10.4B |
+$393M |
-$1.23B |
-$834M |
BGNE, MSFT, ASML, META, AMZN
|
13F-HR |
11/15/2021, 12:27 PM |
Q2 2021 |
299 |
$11.2B |
+$474M |
-$888M |
-$414M |
MSFT, BGNE, META, VALE, ASML
|
13F-HR |
8/16/2021, 01:52 PM |
Q1 2021 |
293 |
$10.8B |
+$596M |
-$1.08B |
-$489M |
BGNE, MSFT, META, ASML, TSLA
|
13F-HR |
5/14/2021, 01:21 PM |
Q4 2020 |
290 |
$10.8B |
+$776M |
-$559M |
+$216M |
MSFT, TSLA, META, AMZN, BGNE
|
13F-HR |
2/12/2021, 06:11 PM |
Q3 2020 |
275 |
$9.08B |
+$1.02B |
-$705M |
+$313M |
BGNE, MSFT, META, AMZN, TSLA
|
13F-HR |
11/13/2020, 01:47 PM |
Q2 2020 |
264 |
$8.2B |
+$1.41B |
-$665M |
+$743M |
MSFT, AMZN, META, BGNE, ASML
|
13F-HR |
8/14/2020, 01:48 PM |
Q1 2020 |
262 |
$5.91B |
+$729M |
-$543M |
+$186M |
MSFT, BABA, META, SGEN, AMZN
|
13F-HR |
5/15/2020, 04:16 PM |
Q4 2019 |
230 |
$7.19B |
+$576M |
-$737M |
-$161M |
MSFT, BGNE, META, BABA, ASML
|
13F-HR |
2/18/2020, 02:50 PM |
Q3 2019 |
221 |
$6.64B |
+$5.38B |
-$99.2M |
+$5.28B |
MSFT, CTRP, BABA, BGNE, ASML
|
13F-HR |
11/14/2019, 02:02 PM |
Q2 2019 |
214 |
$1.43B |
+$673M |
-$83.2M |
+$590M |
CTRP, AMZN, HTHT, META, BGNE
|
13F-HR |
8/14/2019, 03:29 PM |
Q1 2019 |
182 |
$841M |
+$57.1M |
-$93.2M |
-$36.1M |
CTRP, BABA, HTHT, BGNE, MELI
|
13F-HR |
5/15/2019, 03:23 PM |
Q4 2018 |
180 |
$731M |
+$96M |
-$44.4M |
+$51.6M |
CTRP, AMX, BABA, HTHT, BAP
|
13F-HR |
2/14/2019, 03:00 PM |
Q3 2018 |
178 |
$766M |
+$197M |
-$75.9M |
+$121M |
BABA, AMX, MELI, CTRP, BAP
|
13F-HR |
11/14/2018, 03:37 PM |
Q2 2018 |
161 |
$654M |
+$49.7M |
-$59.3M |
-$9.61M |
BABA, MELI, AMX, CTRP, BAP
|
13F-HR |
8/14/2018, 04:06 PM |
Q1 2018 |
165 |
$692M |
+$88.5M |
-$101M |
-$12.5M |
BABA, MELI, AMX, CTRP, BAP
|
13F-HR |
5/15/2018, 04:24 PM |
Q4 2017 |
159 |
$672M |
+$95M |
-$131M |
-$35.9M |
BABA, MELI, AMX, BAP, IBN
|
13F-HR |
2/14/2018, 01:42 PM |
Q3 2017 |
158 |
$684M |
+$53.5M |
-$125M |
-$71M |
BABA, AMX, BAP, VALE, EDU
|
13F-HR |
11/14/2017, 05:11 PM |
Q2 2017 |
158 |
$699M |
+$28.2M |
-$200M |
-$171M |
BABA, AMX, BAP, JD, MELI
|
13F-HR |
8/14/2017, 02:43 PM |
Q1 2017 |
165 |
$821M |
+$32.5M |
-$107M |
-$74.6M |
BABA, AMX, PBR, VALEP, BAP
|
13F-HR |
5/15/2017, 04:15 PM |
Q4 2016 |
161 |
$804M |
+$256M |
-$311M |
-$55.6M |
BABA, VALEP, AMX, PBR, JD
|
13F-HR |
2/15/2017, 07:37 AM |
Q3 2016 |
151 |
$842M |
+$108M |
-$177M |
-$68.6M |
BABA, VALEP, AMX, JD, ITUB
|
13F-HR |
11/14/2016, 06:48 PM |
Q2 2016 |
150 |
$830M |
+$60.4M |
-$149M |
-$88.9M |
VALEP, CX, AMX, ITUB, BABA
|
13F-HR |
8/15/2016, 04:53 PM |
Q1 2016 |
143 |
$911M |
+$62.2M |
-$322M |
-$260M |
VALEP, CX, AMX, MLCO, ITUB
|
13F-HR |
5/16/2016, 02:17 PM |
Q4 2015 |
145 |
$1.13B |
+$147M |
-$117M |
+$30.4M |
AMX, CX, MLCO, VALEP, AES
|
13F-HR |
2/12/2016, 02:58 PM |
Q3 2015 |
141 |
$1.1B |
+$120M |
-$164M |
-$43.6M |
AMX, CX, VALEP, MLCO, IBN
|
13F-HR |
11/16/2015, 04:22 PM |
Q2 2015 |
1 |
$7.08M |
$0 |
$0 |
|
GOOG
|
New Holdings |
9/16/2015, 06:11 PM |
Q2 2015 |
142 |
$1.39B |
+$163M |
-$114M |
+$48.7M |
AMX, CX, MLCO, YPF, IBN
|
13F-HR |
8/14/2015, 04:07 PM |
Q1 2015 |
135 |
$1.33B |
+$151M |
-$216M |
-$65.4M |
CX, MLCO, VALE, IBN, AMX
|
13F-HR |
5/15/2015, 05:15 PM |
Q4 2014 |
4 |
$14.2M |
$0 |
$0 |
|
GOOG, SGEN, HDB, LEG
|
New Holdings |
2/27/2015, 08:07 PM |
Q4 2014 |
132 |
$1.46B |
+$296M |
-$258M |
+$37.8M |
IBN, MLCO, CX, AMX, VALE
|
Restatement |
2/27/2015, 08:06 PM |
Q3 2014 |
126 |
$1.61B |
+$104M |
-$255M |
-$151M |
CX, IBN, MLCO, CIE, GILD
|
13F-HR |
11/14/2014, 02:26 PM |
Q2 2014 |
105 |
$1.89B |
+$174M |
-$603M |
-$428M |
MLCO, CIE, IBN, BBD, CX
|
13F-HR |
8/14/2014, 01:59 PM |
Q1 2014 |
105 |
$2.27B |
+$190M |
-$161M |
+$29.8M |
MLCO, ITUB, BBD, CX, IBN
|
13F-HR |
5/15/2014, 02:26 PM |
Q4 2013 |
102 |
$2.32B |
$0 |
$0 |
|
MLCO, ITUB, GGB, BBD, CX
|
13F-HR |
2/14/2014, 01:30 PM |